VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BigKNY3 who wrote (21761)	5/9/1999 8:56:00 PM
From: Little Gorilla	Read Replies (2) of 23519

BigKNY, you're losing your touch... >>there is not a single Big Pharma that would co-market any pharmaceutical unless it has the potential of over $400 million per year(remember profits are shared with the developer). In fact, Pharma will not even launch their owsource:n products if they do not have the potential to reach over $200 million per year.<< Then, from your own source: >>Drug 1997 1998 1999 2000 2001 2002 phentolamine (VASOMAX) $ -- $ -- $ 30 $ 60 $ 95 $ 130<< Funny, I though SGP had signed on to market Vasomax. Explain please.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next